ARCHIVES

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

This article is from The Cancer Letter archive.

Vol. 24 No. 36 | September 25, 1998

Download PDF Visit The Full Archive

Related Articles

Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs

May 13, 1983

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

House Democrat Seeks Funds for NCI to Pursue 2015 Goal.

June 30, 2006

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995

NCI To Recomplete Frederick Contract To Start In 1977

October 17, 1975

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011